400 related articles for article (PubMed ID: 29400692)
41. Angiomotin-like 2 interacts with and negatively regulates AKT.
Han H; Yang B; Wang W
Oncogene; 2017 Aug; 36(32):4662-4669. PubMed ID: 28368415
[TBL] [Abstract][Full Text] [Related]
42. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
43. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
Li M; Li H; Li C; Wang S; Jiang W; Liu Z; Zhou S; Liu X; McNutt MA; Li G
Int J Cancer; 2011 Feb; 128(3):524-32. PubMed ID: 20473866
[TBL] [Abstract][Full Text] [Related]
44. Wogonin Induces Cell Cycle Arrest and Apoptosis of Hepatocellular Carcinoma Cells by Activating Hippo Signaling.
Wu K; Teng M; Zhou W; Lu F; Zhou Y; Zeng J; Yang J; Liu X; Zhang Y; Ding Y; Shen W
Anticancer Agents Med Chem; 2022; 22(8):1551-1560. PubMed ID: 34431466
[TBL] [Abstract][Full Text] [Related]
45. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
[TBL] [Abstract][Full Text] [Related]
46. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
47. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis.
Xu H; Zhou Y; Liu Y; Ping J; Shou Q; Chen F; Ruo R
J Endocrinol; 2016 May; 229(2):133-44. PubMed ID: 26941037
[TBL] [Abstract][Full Text] [Related]
48. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.
Li X; Liu C; Ip BC; Hu KQ; Smith DE; Greenberg AS; Wang XD
J Exp Clin Cancer Res; 2015 Nov; 34():138. PubMed ID: 26560698
[TBL] [Abstract][Full Text] [Related]
49. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.
Tumaneng K; Schlegelmilch K; Russell RC; Yimlamai D; Basnet H; Mahadevan N; Fitamant J; Bardeesy N; Camargo FD; Guan KL
Nat Cell Biol; 2012 Dec; 14(12):1322-9. PubMed ID: 23143395
[TBL] [Abstract][Full Text] [Related]
50. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
[TBL] [Abstract][Full Text] [Related]
51. Yes-Associated Protein Nuclear Translocation Is Regulated by Epidermal Growth Factor Receptor Activation Through Phosphatase and Tensin Homolog/AKT Axis in Glioblastomas.
Masliantsev K; Mordrel M; Banor T; Desette A; Godet J; Milin S; Wager M; Karayan-Tapon L; Guichet PO
Lab Invest; 2023 May; 103(5):100053. PubMed ID: 36801645
[TBL] [Abstract][Full Text] [Related]
52. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
53. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
Hu J; Che L; Li L; Pilo MG; Cigliano A; Ribback S; Li X; Latte G; Mela M; Evert M; Dombrowski F; Zheng G; Chen X; Calvisi DF
Sci Rep; 2016 Feb; 6():20484. PubMed ID: 26857837
[TBL] [Abstract][Full Text] [Related]
54. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
55. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease.
Cotler SJ; Hay N; Xie H; Chen ML; Xu PZ; Layden TJ; Guzman G
Dig Dis Sci; 2008 Mar; 53(3):844-9. PubMed ID: 17763954
[TBL] [Abstract][Full Text] [Related]
57. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
58. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice.
Hu LL; Su T; Luo RC; Zheng YH; Huang J; Zhong ZS; Nie J; Zheng LP
J Cell Physiol; 2019 Feb; 234(2):1578-1587. PubMed ID: 30078193
[TBL] [Abstract][Full Text] [Related]
59. Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
Mao N; Gao D; Hu W; Gadal S; Hieronymus H; Wang S; Lee YS; Sullivan P; Zhang Z; Choi D; Rosen N; Sawyers CL; Gopalan A; Chen Y; Carver BS
Cancer Res; 2020 Apr; 80(7):1428-1437. PubMed ID: 32015092
[TBL] [Abstract][Full Text] [Related]
60. Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Wu D; Li M; Tian W; Wang S; Cui L; Li H; Wang H; Ji A; Li Y
Sci Rep; 2017 Jul; 7(1):5134. PubMed ID: 28698660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
